Leadership Overview
CROWN has 4 executives leading key functions including strategy, operations, sales, and market expansion.
Driven by a commitment to quality, CROWN provides pharmaceutical and ethical OTC products, alongside contract manufacturing services, to the medical and pharmaceutical industries, impacting market access and product development.
Driven by a commitment to quality, CROWN provides pharmaceutical and ethical OTC products, alongside contract manufacturing services, to the medical and pharmaceutical industries, impacting market access and product development.
Leadership Roles at CROWN
Kurt Wu - Chief Executive Officer
Kurt Wu, the Chief Executive Officer at CROWN, directs the overarching corporate strategy and vision. Wu guides the company's expansion within the pharmaceutical and ethical OTC product sectors, ensuring alignment with market demands and regulatory standards. This leadership role involves fostering innovation in product development and contract manufacturing services, critical components of CROWN's business model. Wu's strategic direction ensures the company maintains its competitive edge in the medical marketplace. Overseeing all executive functions, Kurt Wu drives the company's mission to deliver high-quality pharmaceutical solutions and robust manufacturing capabilities, solidifying CROWN's position as a key industry partner.
Jack Songster - Chief Operating Officer
Jack Songster, the Chief Operating Officer at CROWN, manages daily operations and optimizes production processes for pharmaceutical and ethical OTC products. Songster oversees the contract manufacturing division, ensuring efficient and compliant service delivery to pharmaceutical industry clients. This operational oversight is crucial for maintaining CROWN's reputation for reliability and quality. Songster's focus includes enhancing supply chain logistics and manufacturing efficiency across all CROWN facilities. By streamlining operational workflows, Jack Songster directly supports the company's capacity to meet diverse client needs and expand its market reach within the pharmaceutical sector. The COO's role is central to executing the company's growth strategies through operational excellence.
Evan Penrod - President
Evan Penrod, the President at CROWN, provides executive leadership and strategic oversight across key business units, including pharmaceutical and ethical OTC product distribution. Penrod works closely with the Chief Executive Officer to shape corporate direction and foster growth opportunities within the medical marketplace. This role involves ensuring operational synergy and strategic alignment across all departments. Penrod's responsibilities extend to enhancing CROWN's contract manufacturing services, reinforcing its position as a trusted industry partner. Through dedicated leadership, Evan Penrod contributes significantly to the company's mission of delivering essential pharmaceutical solutions and maintaining high standards of service. The President's influence is critical for driving CROWN's overall success and market impact.
Jennifer Trevethan - Chief Sales Officer (CSO)
Jennifer Trevethan, the Chief Sales Officer (CSO) at CROWN, spearheads all sales initiatives and revenue generation strategies for pharmaceutical and ethical OTC products. Trevethan directs the sales force, cultivating key relationships within the medical marketplace and expanding CROWN's client base. This leadership position is vital for driving market penetration and achieving sales targets. Trevethan's expertise ensures effective go-to-market strategies for new product launches and existing portfolios. By focusing on market dynamics and customer needs, Jennifer Trevethan enhances CROWN's commercial performance and strengthens its industry presence. The CSO's efforts are fundamental to the company's sustained growth and profitability.
Explore Leadership Teams in Manufacturing
Pfizer is a biopharmaceutical company that researches, develops, manufactures, and markets medicines and vaccines across multiple therapeutic areas. The company focuses on areas such as oncology, internal medicine, inflammation and immunology, and vaccines to help prevent, treat, and manage disease worldwide.
Company Leadership BS
JC
NA
SM
AstraZeneca focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca is based in the United Kingdom.
Company Leadership RH
KO

TriRx Pharmaceuticals is a contract development and manufacturing organization specializing in both non-sterile and sterile products, including animal health injectables and packaging solutions. The company offers a wide range of capabilities such as development and analytics, sterile and non-sterile manufacturing, and packaging services. With facilities located in Huntsville, Alabama, and Segré, France, TriRx aims to support customers' commercialization efforts across global markets. Their target clients include pharmaceutical companies looking for advanced solutions to bring their products to market.
Company Leadership RM
KL
JS
SH
Samsung Biologics Co.,Ltd. engages in the contract development and manufacturing organization (CDMO) business for biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates in two segments, CDMO, and Biopharmaceutical Development and Commercialization. Its development services include discovery, cell line development, process development, and clinical manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the research and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates; and manufactures mammalian and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.
Company Leadership BB
TK
YK